Doação de óvulos: Portugal vs France — cost, regulation and timelines

In Portugal, Doação de óvulos typically costs €5,500–€9,000 per private cycle (median ~€7,250). In France, the equivalent range is €4,500–€6,500 (median ~€5,500). France is, on average, ~32% cheaper than Portugal for this technique — the gap is explained by cost-of-living, lab costs and private-market competitive structure.

IMPORTANT: the "cycle price" rarely includes medication (~€1,500–€2,500 extra), annual cryopreservation beyond year one, or add-ons such as PGT. Request a detailed written quote before comparing. For an international patient, the total cost in France also includes flights, accommodation (3–10 nights depending on protocol) and remote follow-up consultations — factors that can erase the base-price gap.

The Portuguese SNS covers free PMA cycles for eligible patients: up to age 40, no shared child with the same partner, and documented clinical indication. Waiting lists run 12–24 months at the main public units. Medication is partially reimbursed by SNS prescription.

In France, Sécurité sociale covers 4 attempts up to age 43 (100% reimbursement); short waiting list. The national regulator, Agence de la biomédecine, sets eligibility rules and maintains a national treatment registry comparable to Portugal's CNPMA.

For patients unwilling to wait for the SNS, the realistic economic comparison weighs: (a) median private cost in Portugal after three competing quotes; (b) total travel + treatment cost in France; (c) audited clinic quality (published outcomes, ESHRE/IFFS membership) — not price alone.

Portugal regulates ART via Lei n.º 32/2006 (amended 2016, 2021), enforced by CNPMA and the Health Regulator (ERS). Each technique — IUI, IVF/ICSI, PGT, gamete donation — requires explicit licensing. Gamete donation is anonymous by default; offspring may access non-identifying donor data at age 18.

In France: Bioethics Law 2021 opened ART to single women and female couples; surrogacy remains banned. The donation model is: Anonymous donation until 2021; since 2022 donors must accept identity disclosure.

For international patients, this comparison matters most in three scenarios: (1) access to techniques unavailable in Portugal (e.g. double anonymous donation with Spain's larger banks); (2) preference for identifiable vs anonymous donors (UK vs Portugal); (3) surrogacy, which is currently very restricted in Portugal — France may or may not offer legal alternatives.

Evaluate in this order: (1) clinical fit — confirm with your clinician that Doação de óvulos is indicated and that the technique is authorised in the country of choice; (2) legal compliance — verify your personal situation (age, marital status, sexual orientation) meets both countries' criteria; (3) total cost comparison — base price plus medication, travel, accommodation, follow-up; (4) auditable clinical quality — ask the clinic for published outcomes, ESHRE European IVF Monitoring registration and ISO 9001 or equivalent; (5) continuity of care — who follows you locally during the two-week post-transfer window and early pregnancy?

Our editorial team does not recommend choosing medical treatment on price alone. A €1,000–€3,000 gap between countries rarely justifies the indirect costs and logistical stress, especially in cycles with low probability of success (maternal age >40, low ovarian reserve). See our international patient guide and patient rights in Portugal.